Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,674.00    16.00 (0.97%)
Bid:
1,664.00
Ask:
1,670.00
Spread: 6.00 (0.361%)
Market Cap: £493.02m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

7 Feb 2013 07:00

RNS Number : 3162X
Avon Rubber PLC
06 February 2013
 



Strictly embargoed until 07:00 Thursday 7 February 2013

 

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 OCTOBER 2012 TO 6 FEBRUARY 2013

 

Introduction

The financial year has started positively and the investments we have made and continue to make in innovative new products and to gain access to new markets have positioned us well to deliver further growth this year.

 

Protection & Defence

In Protection & Defence an improved order book was carried forward into this financial year and included the £14.7m Middle Eastern order announced in May 2012. This has resulted in a stronger first quarter performance compared to the previous year.

 

We have delivered M50 mask systems to the US Department of Defense (DoD) at a similar rate to 2012 and, despite continued uncertainty, we believe that we are well positioned and should not be significantly impacted by US Government cuts in the defence budget. We already have orders in hand for mask systems through to the end of our third quarter. As expected, we delivered 130,000 pairs of M61 filters during the period. We also secured orders for a further 100,000 pairs which we expect to deliver in our second quarter. So far sales to the US homeland security and first responder markets have been significantly stronger than in 2012.

 

Our first new product under Project Fusion was launched during the quarter. The PC50 is an air purifying respirator targeted specifically at the US correctional facilities market. Project Fusion as a whole, which is expected to deliver further organic growth from 2014, remains on track.

 

Dairy

The Milkrite ImpulseAir mouthpiece vented liner continues to perform well and we have seen further quarter on quarter sales growth at our newly established Chinese operation.

 

In other markets lower milk prices and higher feed costs in our traditional markets have reduced farmer revenues and margins, leading to fluctuating demand for our consumable products in the first quarter of our financial year. Planned new product introductions should provide opportunities for growth in the remainder of the year.

 

 

Net debt

The Group's balance sheet remains robust with net debt at 31 December 2012 at £10.1m (30 September 2012: £8.7m) due to the timing of working capital movements and the £1.8m of funding provided to the Employee Share Ownership Trusts to fund the purchase of the Company's shares for awards under the Performance Share Plan. 

 

 

Board changes

As previously announced Sir Richard Needham will retire as a Director at the conclusion of today's Annual General Meeting.

 

Outlook

Given the positive start to the year, the Board is confident of meeting full year market expectations, despite the challenges provided by the uncertain economic and political environment, particularly in the US.

 

Half Year announcement

The Group will announce its results for the half year to 31 March 2013 on Wednesday 1st May 2013.

 

For further enquiries, please contact:

 

 

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Miles Ingrey-Counter, Company Secretary

01225 896850

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

 

NOTES TO EDITORS: Avon is focused on two specialist areas - Protection & Defence and Dairy

With over 120 years' experience, Avon Rubber p.l.c. is an innovative design and engineering group specialising in two core markets, Protection & Defence and Dairy. With a strong emphasis on research and development, we design, test and manufacture specialist products from a number of sites in the US and the UK, serving markets around the world.

Avon Protection is the recognised global market leader in advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection system technology. Our unrivalled 80 year pedigree in military mask design and manufacture has placed Avon Protection's products at the heart of many international defence and tactical Personal Protective Equipment (PPE) deployment strategies. Our expanding global customer base now includes military forces, civil and first line defence troops, emergency service teams and industrial, marine, mineral and oil extraction site personnel. All put their trust in Avon's advanced respiratory solutions.

Our world leading Dairy business and its Milkrite brand have a global market presence. Our unique designs and innovative technology are described by one particular customer as "the biggest advance in the milking process in a generation". Working with the leading scientists and health specialists in the industry, we continue to invest in technology to further improve the milking process and animal welfare. As our market share and milking experience continues to grow so does our global presence.

For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSFFAMFDSESE
Date   Source Headline
2nd Feb 20221:30 pmRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSTransaction in Own Shares
28th Jan 20221:00 pmRNSResult of AGM
28th Jan 20227:00 amRNSLaunch of Share Buyback Programme
28th Jan 20227:00 amRNSAnnual General Meeting - Trading Update
21st Jan 20227:01 amEQSEdison Investment Research Limited: Avon Protection (AVON): Refocused Protection set to resume growth
19th Jan 202211:00 amRNSAGM update
14th Jan 20224:00 pmRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSChief Financial Officer Appointment
21st Dec 20212:00 pmRNSDirector/PDMR Shareholding
21st Dec 20212:00 pmRNSDirector/PDMR Shareholding
17th Dec 20214:00 pmRNSNotice of Annual Report and AGM
16th Dec 20215:00 pmRNSHolding(s) in Company
15th Dec 20213:00 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSFinal Results
7th Dec 20214:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSNotice of Results
17th Nov 20213:00 pmRNSHolding(s) in Company
16th Nov 20216:00 pmRNSHolding(s) in Company
16th Nov 20212:00 pmRNSHolding(s) in Company
16th Nov 202112:00 pmRNSHolding(s) in Company
16th Nov 20219:00 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSBody armor strategic review
9th Nov 202111:00 amRNSDirector/PDMR Shareholding
13th Oct 20213:00 pmRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSPost Close Trading Update
27th Sep 20216:00 pmRNSDirector/PDMR Shareholding
27th Sep 20215:00 pmRNSHolding(s) in Company
24th Sep 20213:00 pmRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSU.S. Defense Logistics Agency Body Armor Contract
17th Sep 20216:00 pmRNSHolding(s) in Company
17th Sep 20214:00 pmRNSHolding(s) in Company
8th Sep 20211:00 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSU.S. DOD next generation ballistic helmet contract
31st Aug 20215:00 pmRNSHolding(s) in Company
31st Aug 20214:00 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
16th Aug 20217:00 amRNSExchange Rate for Interim Dividend
13th Aug 20219:00 amRNSHolding(s) in Company
13th Aug 20217:00 amRNSTrading Update
6th Aug 202111:00 amRNSDirector/PDMR Shareholding
14th Jul 20217:00 amRNSChange of Company Name
12th Jul 20215:00 pmRNSDirector/PDMR Shareholding
12th Jul 20215:00 pmRNSHolding(s) in Company
7th Jul 20214:00 pmRNSDirector/PDMR Shareholding
10th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 202110:00 amRNSDirector/PDMR Shareholding
27th May 20212:00 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSBoard change
25th May 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.